Vectors TRIZ Cases

HI loop mutations in AAV8 capsids enhance bipolar cell transduction efficiency while maintaining stability.

Engineered AAV9 capsids enable systemic gene delivery to motor neurons, bypassing invasive intracranial procedures required for traditional treatments.

Modified hepatitis post-transcriptional regulatory elements enhance recombinant protein production through engineered nucleotide sequences.

RN1250 recombinant vaccine utilizes reticuloendotheliosis virus long terminal repeat sequences to elicit protective immune responses in chickens.

A nucleic acid sequence derived from the retinal G protein-coupled receptor gene drives targeted expression in Müller cells.

Segmented otoferlin vectors overcome size constraints to express full-length protein and restore hearing function.

VTvaf17 vectors deliver therapeutic genes via extraction of antibiotic resistance markers, resolving safety concerns in mucociliary treatment.

Specific promoter and polyA signal combinations increase antibody-producing cell counts while reducing time required to identify high-producing clones.

Covalently closed circular RNA molecules enable sustained protein expression through efficient translation mechanisms.

Non-ATG start codons impair marker translation, filtering low-expression clones and reducing gene silencing during host cell selection.

KTR27-F fusogenic oncolytic herpes simplex virus 1 variant uses tetracycline operators and ribozymes to control viral replication.

A curing vector eliminates residual editing vectors via anti-target gRNA, restoring native cellular states for recursive genomic modifications.

Liver-specific rAAV vectors restore PAH function without nuclease-induced off-target mutations.

Membrane-bound biotin mimetic peptides enable flow cytometry sorting, replacing manual cloning to increase protein productivity by 13.5-fold.

AAV9 vectors deliver IDUA genes to the CNS, preventing neurocognitive decline without lifelong infusions.

A multi-cistronic plasmid encodes insulin with TGF-beta and IL-10 to induce antigen-specific regulatory T cells.

Selective promoter expression in inner ear supporting cells repairs sensorineural hearing loss without hair cell toxicity.

A lentiviral vector uses the bLCR-EFS promoter to drive high-level transgene expression in hematopoietic stem cells.

A DCX regulatory sequence drives transient expression in proliferative neuronal determined cells to enable specific marker identification.

Hybrid promoter merges viral core elements with distal enhancers to resolve the trade-off between strong transcription and cell-type specificity.

Synthetic forskolin-inducible promoters replace toxic sugar inducers with small molecules, reducing costs and simplifying purification in bioprocessing.

Nucleic acid constructs with reporter genes enable multiplexed screening of chemical perturbations on RNA structures.

A modified protein C polypeptide with an inserted self-cleaving site generates activated protein C directly from recombinant expression.

S264A mutation blocks ubiquitination, preventing proteasome degradation and increasing transduction efficiency.

Novel nucleic acid promoter drives high-level gene expression in retinal endothelial cells.

A recombinant bacterium uses peroxidase to degrade cell membrane lipids into free fatty acids without causing cell lysis.

Albumin-derived 3'UTR elements stabilize artificial nucleic acid molecules against degradation, prolonging protein expression in gene therapy.

The WXRE transcriptional regulatory element boosts heterologous protein production in mammalian expression systems.

Nanocapsules encapsulate SCUBE3 mRNA, resolving poor targeting and daily injection needs.

Modified adenovirus introduces an AU-rich element into the 3′-untranslated region to regulate E1A gene expression via local quality principles.

Targeted insertion into safe harbor loci reduces off-target effects and vector doses while maintaining therapeutic enzyme activity.

Recombinant adeno-associated virus vectors deliver codon-optimized neuroreceptor genes to reduce conventional drug dosages and side effects.

Inserting N-x-(T/I/V/A)-(K/R) sequences into the AAV vp3 region increases transduction efficiency of deep brain cells while maintaining vector safety profiles.

Synthetic polypeptides from RFS genes delay flowering to boost biomass while overcoming germplasm limitations.